Embracing pharma’s digital transformation
In his first regular column for GOLD, Davidek Herron discusses digital transformation in pharma, and how the industry can pursue operational excellence.
Is the biotech boom on thin ice?
After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future looks more promising as investors push for disruptive innovation.
Kenya is home to a budding pharma sector, but the country is still blighted by a series of access to medicine challenges. What are these, and how can pharma help?
Future the biotech rise, fall
This infographic explores the biotech rise and marginal fall over the past five years, tracking revenue, funding levels and drug approvals.